Insulet

company

About

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System.

  • 501 - 1000

Details

Last Funding Type
Series C
Last Funding Money Raised
$22M
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2000
Number Of Employee
501 - 1000
Operating Status
Active

Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes primarily in the United States. The company offers OmniPod Insulin Management System (OmniPod System), an insulin infusion system that provides a pain-free automated cannula insertion. The OmniPod System consists of OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager; and provides people with a diabetes management solution that offers lifestyle and other benefits. The company sells the OmniPod System directly to patients through referrals from healthcare professionals and through patient leads.

Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$68.50M
Insulet has raised a total of $68.50M in funding over 2 rounds. Their latest funding was raised on Mar 2, 2004 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 2, 2004 Series D $35.50M 1 Detail
Oct 7, 2002 Series C $22M 1 Versant Ventures Detail
Aug 8, 2001 Series B $11M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Insulet is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Series D